This is a routine pre-planned director sale with no material signal for the stock. Monitor for any acceleration of insider selling or changes in insider sentiment, but this filing alone does not warrant a trading response.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 7 $115.67entry
- T+1 · 3mo ago +7.96%α +7.99% · $124.88
- T+5 · 3mo ago +2.51%α +2.11% · $118.57
- T+20 · 2mo ago +7.82%α +8.22% · $124.72
- T+60 · 15d ago +32.08%α +34.35% · $152.78
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director Robert Chess filed a Form 144 notice to sell 18,417 shares of Twist Bioscience common stock, valued at approximately $2.04 million, pursuant to a 10b5-1 plan adopted on May 8, 2026. The sale is tied to a stock option exercise and represents a routine, pre-planned transaction by a director.
Key Facts
- Director Robert Chess intends to sell 18,417 shares of TWST common stock.
- Estimated market value of the proposed sale is $2,042,261.13.
- Sale is related to a stock option exercise on August 7, 2026.
- The 10b5-1 trading plan was adopted on May 8, 2026.
- Shares represent approximately 0.03% of TWST's $6.8B market cap.
Financial Impact
Proposed sale of ~$2.04M, or ~0.03% of market cap.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (TWST), Batch item 1 | 0001959173-26-005735 |
| Document: 0001959173-26-005735-index.html | 0001959173-26-005735 |
| Document: 0001959173-26-005735.txt | 0001959173-26-005735 |
| 144 Filing (TWST), Batch item 4 | 0001959173-26-005735 |
| Document: 0001959173-26-005735-index.html | 0001959173-26-005735 |
| Document: 0001959173-26-005735.txt | 0001959173-26-005735 |
Track record
47 reports on TWST
8 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +55.24% at T+60 after the Aug 3, 2026 report. 10 of 12 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.03 Now $111.60 +6.26% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.16 Now $111.60 +6.12% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $104.98 Now $111.60 +6.31% settles Dec 15
- Nov 16, 2026today 144 Neutral 2/10 Entry $105.61 Now $111.60 +5.67% settles Dec 15
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $104.03 Now $111.60 +7.28% settles Dec 15
- Nov 12, 20264d ago 8-K Bullish 6/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 12, 20264d ago SC 13G/A Neutral 2/10 Entry $114.22 Now $111.60 −2.29% settles Dec 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $132.13 Now $111.60 −15.54% settles Dec 9
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $120.79 Now $111.60 −7.61% settles Dec 7
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $120.61 Now $111.60 −7.47% settles Dec 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers